Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

LNTH Lantheus Holdings Inc

88,80

-0,66 (-0,74%)

03 Gen 2025 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

07/10/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

05/17/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Bradley Camilo, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gary J. Pruden

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Lantheus (NASDAQ:LNTH)
Storico
Da Dic 2024 a Gen 2025

Clicca qui per i Grafici di Lantheus

Grafico Azioni Lantheus (NASDAQ:LNTH)
Storico
Da Gen 2024 a Gen 2025

Clicca qui per i Grafici di Lantheus

Notizie Lantheus Holdings Inc - LNTH

Form 8-K - Current report
Lunedì 23 Dicembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 19 Dicembre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Mercoledì 20 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Lantheus Announces Share Repurchase Program
Mercoledì 20 Novembre 2024 (1 mese fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 19 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 18 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 15 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Giovedì 14 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Lantheus to Present at the Jefferies London Healthcare Conference
Mercoledì 13 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 12 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
Lunedì 11 Novembre 2024 (2 mesi fa) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Venerdì 8 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)

Più Lantheus Holdings Inc Articoli Notizie

Fidelity Yield Enhanced ...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea